Aktie A1JGA8 CHINA NT PHARMA GROUP COMPANY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen China NT Pharma Group Company Limited

Aktien

A1JGA8

KYG2114L1059

1011

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:49 06.05.2024 		% 5 Tage % 1. Jan.
0,025 HKD 0,00 % Intraday Chart für China NT Pharma Group Company Limited -3,85 % -54,55 %
28.03. China NT Pharma Group Company Limited meldet die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
15.01. China Nt Pharma Group Company Limited kündigt Änderungen im Vorstand an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
China NT Pharma Group Company Limited Announces Directorate Changes
China NT Pharma Group Company Limited Announces Change of Company Secretary, Effective 31 December 2023
China NT Pharma Group, Private Equity Fund Sign Cooperation Agreement; Shares Rise 4%
China NT Pharma Raises HK$13 Million from Private Placement
NT Pharma Seeks Nearly HK$24 Million from Share Placement
China NT Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
China NT Pharma Lays Out Restructuring Plan for Embattled Unit Suzhou First Pharma
China NT Pharma Unit Faces Lawsuits for Alleged Loan Default
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
China Nt Pharma Group Company Limited Announces Change of Independent Non-Executive Director and Member of Audit Committee
Konruns Pharma Cancels Osteoporosis Drug Agreement With NT Pharma, US-based Pfenex
China NT Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
China NT Pharma Group Company Limited Announces Resignation of Wu Weizhong as Executive Director and Senior Vice President
China NT Pharma Signs Licensing Deal with US Company for Antibody Products
China NT Pharma Group Company Limited Intends to Set Up A Joint Venture Company
China NT Pharma Group Company Limited Updates on Delay in Publication of Audited Annual Results for the Year Ended 31 December 2021
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
China NT Pharma : NOTICE OF BOARD MEETING
China NT Pharma : Narrows H1 Loss on Increased Antipsychotic Drug Sales
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1JGA8 Aktie
  4. Nachrichten China NT Pharma Group Company Limited
  5. Andere Sprachen